Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://t.co/dbHrFsg1Km @DKFZ @IARCWHO @PLUS_1622 @UdL_RDI @CeMM_News @ULBRecherche @UniOslo @bionanonet
Buffy coat signatures of breast cancer risk in a prospective cohort study.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Sep 2023Where it's discussed
-
X / Twitter7 posts
-
News2 articles
-
YouTube1 videos
AI synopsis
What people are saying
Overall, discussions show a supportive tone with one user expressing happiness about the publication, highlighting collaboration and recognition in the scientific community. The tone is professional, with phrases like 'happy to see' and 'congratulations,' emphasizing acknowledgment rather than deep debate or critique.
The only detailed discussion celebrates the publication, indicating support and recognition of its scientific contribution.
Most posts are neutral or brief acknowledgments, suggesting a moderate level of interest, though not highly enthusiastic.
Comments referencing the research process and congratulatory notes show some active engagement and appreciation for the work.
The publication is viewed as potentially impactful given the mention of institutional contributors and the significance of early detection research.
Abstract in brief
- The study analyzed blood samples from a large group of women over time and found specific DNA methylation patterns in blood cells that are associated with breast cancer risk, even years before diagnosis.
- Researchers used advanced sequencing and machine learning to identify and predict cancer-related changes in blood DNA, achieving up to 75% accuracy in detecting future breast cancer cases.
- The findings suggest that epigenetic changes in blood could serve as early markers for breast cancer risk, potentially enabling earlier intervention and personalized prevention strategies.]
Top posts
Most liked on X and BlueskyBuffy coat signatures of breast cancer risk in a prospective cohort study https://t.co/PovTqi7o0k
Buffy coat signatures of breast cancer risk in a prospective cohort study https://t.co/J5S1wOpTCG
RT @MarinaLaplana: Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://…
Buffy coat signatures of breast cancer risk in a prospective cohort study https://t.co/GOGjkas0Ob https://t.co/parDi8nyOi
RT @MarinaLaplana: Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://…
All mentions
Epigenetic Blood Markers Predict Breast Cancer Risk in Cohort Study
The study analyzed blood samples from women over time, finding DNA methylation patterns linked to breast cancer risk years before diagnosis. Using advanced sequencing and machine learning, the researchers achieved up to…
Buffy coat signatures of breast cancer risk in a prospective cohort study https://t.co/J5S1wOpTCG
RT @MarinaLaplana: Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://…
RT @MarinaLaplana: Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://…
Buffy coat signatures of breast cancer risk in a prospective cohort study https://t.co/PovTqi7o0k
RT @MarinaLaplana: Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://…
Happy to see our last work published in #clinicalepigenetics. Congratulations to Dr Chung and all contributors. https://t.co/dbHrFsg1Km @DKFZ @IARCWHO @PLUS_1622 @UdL_RDI @CeMM_News @ULBRecherche @UniOslo @bionanonet
Buffy coat signatures of breast cancer risk in a prospective cohort study https://t.co/GOGjkas0Ob https://t.co/parDi8nyOi